CUTIVATE

This brand name is authorized in United States. It is also authorized in Cyprus, Ecuador, Estonia, Hong Kong SAR China, Lithuania, Malta, Mexico, Netherlands, Poland, Romania, Singapore, South Africa, Turkey, UK.

Active ingredients

The drug CUTIVATE contains one active pharmaceutical ingredient (API):

1	Fluticasone UNII O2GMZ0LF5W - FLUTICASONE PROPIONATE
	Fluticasone has anti-inflammatory and vasoconstrictive features. Fluticasone given by inhalation at recommended doses has a potent glucocorticoid anti-inflammatory action within the lungs, resulting in a reduction of both symptoms and exacerbations of asthma, with a lower incidence and severity of adverse effects than those observed when corticosteroids are administered systemically.
	Read more about Fluticasone

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
CUTIVATE Lotion	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
D07AC17	Fluticasone	D Dermatologicals → D07 Corticosteroids, dermatological preparations → D07A Corticosteroids, plain → D07AC Corticosteroids, potent (group III)
Discover more medicines within D07AC17

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	24.370-1-01-12
EE	Ravimiamet	1004847, 1006344, 1062087, 1062098
GB	Medicines & Healthcare Products Regulatory Agency	158443
HK	Department of Health Drug Office	37755
LT	Valstybinė vaistų kontrolės tarnyba	1000528, 1000530, 1022726, 1022727, 1079991, 1079992, 1081957, 1081958, 1084826, 1084875, 1085199, 1085794, 1087810, 1087811
MT	Medicines Authority	MA192/03801
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	210M97
NL	Z-Index G-Standaard	13803735
NL	Z-Index G-Standaard, PRK	38626, 38628, 38636
PL	Rejestru Produktów Leczniczych	100016334, 100016340
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W65211001, W65212001
SG	Health Sciences Authority	08628P
TR	İlaç ve Tıbbi Cihaz Kurumu	8699522385041
US	FDA, National Drug Code	10337-333, 10337-434
ZA	Health Products Regulatory Authority	27/13.4.1/0441, 27/13.4.1/0442